Hi ,

• U.S. Bolsters Biotech Workforce: An Inside Look at the New White House Action Plan. Under the Biden-Harris administration, an ambitious strategy has been unveiled to dramatically bolster biotechnology and biomanufacturing education and job training initiatives nationwide.

• AI Uncovers Novel Proteins for Base Editing: In a significant stride towards advancing the biotechnology field, investigators from the Chinese Academy of Sciences' Institute of Genetics and Developmental Biology have trailblazed an AI-assisted method to unearth novel deaminase proteins.

  
  

• Transforming Food Processing Wastewater: Novel Approach Receives $9M in Seed Funding. In a recent announcement that underscores the rise of waste-to-value technologies in an effort to counter environmental and economic challenges, Hyfé, a pioneer in transforming food processing wastewater into sustainable feedstocks and clean water, has raised a solid $9 million in an oversubscribed seed investment round.

• Amyris CEO John Melo Steps Down, Company to Undergo Workforce Reduction. In a shake-up at the top, Amyris, Inc., a pioneer in the synthetic biotechnology field, has announced the resignation of John Melo, its President & Chief Executive Officer and member of the Board of Directors.

• PhageLab, a company that develops custom phage-based solutions that reduce the need for antibiotics, has been featured in BBC Sounds: The captivating segment is called "The coolest science in the world" and is a part of the Unexpected Elements podcast.

Other news:

• A Boon for Biomaterials: NSF Invests Heavily in Advanced Materials Research Centers.

• Understanding the Inner Workings of Spider Silk: A Leap Toward Synthetic Production.

• Designing Cell-Free, Biologically Active Architecture: In a poetic blend of science and art, Laia Mogas-Soldevila is creating an unusual and innovative type of architectural technology.

• Innovative Use of mRNA and CAR-T Therapy Offers Hope for Myasthenia Gravis Patients.

• Taste the Sun: Gene Editing Produces Vitamin D Enhanced Tomatoes (GEN)

• Suddenly, It Looks Like We’re in a Golden Age for Medicine: We may be on the cusp of an era of astonishing innovation — the limits of which aren’t even clear yet. (The New York Times)

• What’s Next For The U.S. Bioeconomy? Defining It. (FAS)

• Christopher Voigt named head of the Department of Biological Engineering: Synthetic biology expert to succeed Angela Belcher as department head effective Aug. 1. (MIT)

• Primetals Technologies and LanzaTech announce renewal of ten-year cooperation to advance industry transition to green steel (Press release)
  

• Joyful Ventures debuts with $23M focused on investment in sustainable protein startups. (TechCrunch)
  

Regards,
Jeff

---

Jeff Buguliskis, PhD 

Director of Content, SynBioBeta

Who's hiring?

• Scientist - Bioprocessing at Macro Oceans (Sacramento, CA)

• Process Engineering Director at Macro Oceans (Sacramento, CA)

• Senior Government Team Coordinator at LanzaTech (Skokie, IL)

• Software Engineer at Latch Bio (San Francisco, CA)

• Summer 2023 Business Operations (Internship) at Latch Bio (San Francisco, CA)

• Bioprocess Lab Technician at Solugen (Houston, TX)

• Senior Scientist - Strain Engineering at Solugen (Houston, TX)

• Senior Scientist I – Protein Engineering at Solugen (Houston, TX)

• Scientist II – Heterogeneous Metals Catalysis at Solugen (Houston, TX)

• Sr. Compensation Analyst at Solugen (Houston, TX)

• Director/Senior Director, Quality & Compliance (GxP) at Bit.bio (Cambridge, UK)

• Director/Senior Director, Marketing (Research Products) at Bit.bio (Cambridge, UK)

• SVP, Pharma Business Development & Cell Therapy Partnerships at Bit.bio (Boston, MA)

• Scientist/Senior Scientist, Technical Operations at Bit.bio (Boston, MA)

• Scientist/Senior Scientist, Cell Type Development (Neuro) at (Cambridge, UK)

• Director- Laboratory Operations at Twist Bioscience (Quincy, MA)

• Senior Research Associate: Protein/Enzyme Engineering at Twist Bioscience (South San Francisco, CA)

• Account Manager, Antibody Discovery Services at Twist Bioscience (NY)

• Director – Molecular Biology and Antibody Engineering at Twist Bioscience (Quincy, MA)

• Director, SEC Reporting and Technical Accounting at Twist Bioscience (San Francisco, CA)

• Senior Scientist, RNA Therapeutics at Ginkgo Bioworks (Boston, MA)

• Senior Director, Gene Therapy at Ginkgo Bioworks (Boston, MA)

• Director/Senior Director, Business Development - RNA at Ginkgo Bioworks (Boston, MA)

• Director/Senior Director, Business Development - Pharma Enterprise Sales at Ginkgo Bioworks (Boston, MA)

• Director/Senior Director, Business Development - Pharma Enterprise Sales at Ginkgo Bioworks (Boston, MA)

• Director, Business Development, Cell Engineering at Ginkgo Bioworks (Boston, MA)

• Senior Bioinformatics Engineer at Ginkgo Bioworks (Boston, MA)

• Associate Director, Lab Enablement at Ginkgo Bioworks (Boston, MA)

• Chief Strategy & Bioeconomic Development Officer at BioMADE (US)

• Multiple Positions with the National Security Commission on Emerging Biotechnology (NSCEB)

• Scientist II/Scientist III, Microbial Innovation Group at Inscripta (Pleasanton, CA)

• Senior/Staff Research Associate, Molecular Biology at Inscripta (Pleasanton, CA)

• Research Associate II/III, Analytical Chemistry at Inscripta (Pleasanton, CA)